Riemenschneider M - Search Results

1

Study protocol: randomised controlled trial evaluating exercise therapy as a supplemental treatment strategy in early multiple sclerosis: the Early Multiple Sclerosis Exercise Study (EMSES).

Riemenschneider M, Hvid LG, Ringgaard S, Nygaard MKE, Eskildsen SF, Petersen T, Stenager E, Dalgas U. Riemenschneider M, et al. BMJ Open. 2021 Jan 12;11(1):e043699. doi: 10.1136/bmjopen-2020-043699. BMJ Open. 2021. PMID: 33436475 Free PMC article.

2

Balance and walking performance are improved after resistance and aerobic training in persons with chronic stroke.

Lund C, Dalgas U, Grønborg TK, Andersen H, Severinsen K, Riemenschneider M, Overgaard K. Lund C, et al. Among authors: riemenschneider m. Disabil Rehabil. 2018 Oct;40(20):2408-2415. doi: 10.1080/09638288.2017.1336646. Epub 2017 Jun 9. Disabil Rehabil. 2018. PMID: 28597708 Clinical Trial.

3

Performed and perceived walking ability in relation to the Expanded Disability Status Scale in persons with multiple sclerosis.

Langeskov-Christensen D, Feys P, Baert I, Riemenschneider M, Stenager E, Dalgas U. Langeskov-Christensen D, et al. Among authors: riemenschneider m. J Neurol Sci. 2017 Nov 15;382:131-136. doi: 10.1016/j.jns.2017.09.049. Epub 2017 Oct 3. J Neurol Sci. 2017. PMID: 29111007

4

Is there an overlooked "window of opportunity" in MS exercise therapy? Perspectives for early MS rehabilitation.

Riemenschneider M, Hvid LG, Stenager E, Dalgas U. Riemenschneider M, et al. Mult Scler. 2018 Jun;24(7):886-894. doi: 10.1177/1352458518777377. Mult Scler. 2018. PMID: 29889008 Review.

5

Physical activity is associated with neuromuscular and physical function in patients with multiple sclerosis independent of disease severity.

Rooney S, Riemenschneider M, Dalgas U, Jørgensen MK, Michelsen AS, Brønd JC, Hvid LG. Rooney S, et al. Among authors: riemenschneider m. Disabil Rehabil. 2021 Mar;43(5):632-639. doi: 10.1080/09638288.2019.1634768. Epub 2019 Jul 7. Disabil Rehabil. 2021. PMID: 31282207

6

Exercise as Medicine in Multiple Sclerosis-Time for a Paradigm Shift: Preventive, Symptomatic, and Disease-Modifying Aspects and Perspectives.

Dalgas U, Langeskov-Christensen M, Stenager E, Riemenschneider M, Hvid LG. Dalgas U, et al. Among authors: riemenschneider m. Curr Neurol Neurosci Rep. 2019 Nov 13;19(11):88. doi: 10.1007/s11910-019-1002-3. Curr Neurol Neurosci Rep. 2019. PMID: 31720862 Review.

7

A Head-to-Head Comparison of an Isometric and a Concentric Fatigability Protocol and the Association With Fatigue and Walking in Persons With Multiple Sclerosis.

Taul-Madsen L, Dalgas U, Kjølhede T, Hvid LG, Petersen T, Riemenschneider M. Taul-Madsen L, et al. Among authors: riemenschneider m. Neurorehabil Neural Repair. 2020 Jun;34(6):523-532. doi: 10.1177/1545968320920250. Epub 2020 May 12. Neurorehabil Neural Repair. 2020. PMID: 32396032

8

Time matters: Early-phase multiple sclerosis is accompanied by considerable impairments across multiple domains.

Thrue C, Riemenschneider M, Hvid LG, Stenager E, Dalgas U. Thrue C, et al. Among authors: riemenschneider m. Mult Scler. 2021 Sep;27(10):1477-1485. doi: 10.1177/1352458520936231. Epub 2020 Jul 2. Mult Scler. 2021. PMID: 32613902

9

Comparison Between Isometric and Concentric Motor Fatigability in Persons With Multiple Sclerosis and Healthy Controls - exploring central and peripheral contributions of motor fatigability.

Gaemelke T, Riemenschneider M, Dalgas U, Kjølhede T, Rasmussen C, Stenager E, Overgaard K, Hvid LG. Gaemelke T, et al. Among authors: riemenschneider m. Neurorehabil Neural Repair. 2021 Jul;35(7):644-653. doi: 10.1177/15459683211017502. Epub 2021 May 22. Neurorehabil Neural Repair. 2021. PMID: 34027727

10

Investigating the potential disease-modifying and neuroprotective efficacy of exercise therapy early in the disease course of multiple sclerosis: The Early Multiple Sclerosis Exercise Study (EMSES).

Riemenschneider M, Hvid LG, Ringgaard S, Nygaard MKE, Eskildsen SF, Gaemelke T, Magyari M, Jensen HB, Nielsen HH, Kant M, Falah M, Petersen T, Stenager E, Dalgas U. Riemenschneider M, et al. Mult Scler. 2022 Sep;28(10):1620-1629. doi: 10.1177/13524585221079200. Epub 2022 Mar 16. Mult Scler. 2022. PMID: 35296183 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

291 results

Search Page